Advice
Following an abbreviated submission
levetiracetam 500mg/5ml concentrate for infusion (Keppra) is accepted for use in NHS Scotland as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. It is an alternative when oral administration is temporarily not feasible in patients for whom levetiracetam is an appropriate anticonvulsant.
Intravenous infusion is associated with a greater cost per dose.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- levetiracetam 500mg/5ml concentrate for infusion (Keppra)
- SMC ID:
- 311/06
- Indication:
- Epilepsy
- Pharmaceutical company
- UCB Pharma Ltd
- BNF chapter
- Central nervous system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 09 October 2006